Literature DB >> 25148912

[Elective organ and function preservation in ureter and renal pelvis tumors].

S Rausch1, G Gakis, J Bedke, A Stenzl.   

Abstract

With the technical innovations of smaller, flexible ureteroscopes, color-filtered imaging, and endoscopic laser technology, organ-preserving treatment for upper urinary tract transitional cell carcinoma has become feasible. While in the past, radical nephroureterectomy was the sole gold standard approach for the treatment of upper urinary tract tumors, the endoscopic approach is no longer restricted to only patients with the imperative indication of kidney preservation. Initial clinical results have demonstrated oncologic efficacy of endoscopic management or segmental ureteral resection. However, careful preoperative risk-assessment and close endoscopic follow-up are mandatory.

Entities:  

Mesh:

Year:  2014        PMID: 25148912     DOI: 10.1007/s00120-014-3557-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  47 in total

1.  Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter.

Authors:  Akira Irie; Masatsugu Iwamura; Kazuomi Kadowaki; Asako Ohkawa; Toyoaki Uchida; Shiro Baba
Journal:  Urology       Date:  2002-01       Impact factor: 2.649

2.  Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy.

Authors:  Naoki Takahashi; James F Glockner; Robert P Hartman; Bernard F King; Bradley C Leibovich; David W Stanley; Patrick D Fitz-Gibbon; Akira Kawashima
Journal:  J Urol       Date:  2010-02-19       Impact factor: 7.450

3.  A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.

Authors:  Claudio Jeldres; Maxine Sun; Hendrik Isbarn; Giovanni Lughezzani; Lars Budäus; Ahmed Alasker; Shahrohk F Shariat; Jean-Baptiste Lattouf; Hugues Widmer; Daniel Pharand; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Urology       Date:  2009-12-06       Impact factor: 2.649

4.  European guidelines on upper tract urothelial carcinomas: 2013 update.

Authors:  Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard Sylvester; Max Burger; Nigel Cowan; Andreas Böhle; Bas W G Van Rhijn; Eero Kaasinen; Joan Palou; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2013-03-19       Impact factor: 20.096

5.  Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.

Authors:  Wolfgang Otto; Shahrokh F Shariat; Hans-Martin Fritsche; Amit Gupta; Kazumasa Matsumoto; Wassim Kassouf; Guido Martignoni; Thomas J Walton; Stefan Tritschler; Shiro Baba; Patrick J Bastian; Juan I Martínez-Salamanca; Christian Seitz; Armin Pycha; Maximilian Burger; Pierre I Karakiewicz; Vincenzo Ficarra; Giacomo Novara
Journal:  World J Urol       Date:  2011-01-20       Impact factor: 4.226

6.  Narrow-band imaging digital flexible ureteroscopy in detection of upper urinary tract transitional-cell carcinoma: initial experience.

Authors:  Olivier Traxer; Bogdan Geavlete; S Gil Diez de Medina; Matilde Sibony; Saeed M Al-Qahtani
Journal:  J Endourol       Date:  2011-01       Impact factor: 2.942

7.  Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival.

Authors:  Pierre Colin; Adil Ouzzane; David R Yates; François Audenet; Audenet François; Géraldine Pignot; Alexis Arvin-Berod; Olivier Merigot de Treigny; Guy Laurent; Antoine Valeri; Jacques Irani; Irani Jacques; Fabien Saint; Solène Gardic; Pascal Gres; François Rozet; Yann Neuzillet; Alain Ruffion; Morgan Rouprêt
Journal:  Ann Surg Oncol       Date:  2012-07-28       Impact factor: 5.344

8.  Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.

Authors:  George N Thalmann; Regula Markwalder; Bernhard Walter; Urs E Studer
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

Review 9.  Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.

Authors:  Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Marie-France Bellin; Michele Bertolotto; Georg Bongartz; Olivier Clement; Peter Leander; Gertraud Heinz-Peer; Peter Reimer; Fulvio Stacul; Aart van der Molen; Judith A W Webb
Journal:  Eur Radiol       Date:  2012-08-04       Impact factor: 5.315

10.  Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy.

Authors:  Shahrokh F Shariat; Guilherme Godoy; Yair Lotan; Michael Droller; Pierre I Karakiewicz; Jay D Raman; Hendrik Isbarn; Alon Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Christian Bolenz; Karim Bensalah; Theresa M Koppie; Wassim Kassouf; Jeffrey C Wheat; Richard Zigeuner; Cord Langner; Christopher G Wood; Vitaly Margulis
Journal:  BJU Int       Date:  2009-11-13       Impact factor: 5.588

View more
  1 in total

Review 1.  Optical improvements in the diagnosis of bladder cancer: implications for clinical practice.

Authors:  Tina Schubert; Steffen Rausch; Omar Fahmy; Georgios Gakis; Arnulf Stenzl
Journal:  Ther Adv Urol       Date:  2017-09-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.